Dendritic cells and Class II MHC/HLA Flashcards
In vivo Dendritic cells are derived form
CD34+ bone marrow stem cells
In vivo immature dendritic cell differentiation
under influence of GM-CSF, M-CSF, Flt3 ligand. Myeloid precursors enter circulation and differentatie to dendritic cells
In vivo maturation of dendritic cells
mature after they endocytose an antigen
In Vitro dendritic cell precursors
Blood monocytes or CD24+
to differentiate dendritic cells invitro add
GM-CSF, Flt3, IL-4
FLt3 receptor is also known as
CD135
Role of dendritic cells
- antigen presentation
- link innate immunity to adaptive immunity (+cytokines)
- secrete cytokines( IL12,15,18,23)
- capture antigen and transport to secondary lymphoid tissue to present to CD4+(immature)
Distribution of dendritic cells
all lymphoid and non lymphoid tissue except brain
Phenotype for dendritic cell and other APCs for antigen presentation
HLA-Class II, B7-1/CD80, B7-2/CD86
other cell surface molecules of dendritic cells
Fc-gamma-R, CD-40, LFA-3, ICAM1, ICAM2
Structure of Class II MHC
Heterodimer, isoypes DP, DQ, DR. Binds antigenic fragments of 15-30 amino acids long
properties of Class II MHC
- only expresed on APC’s
- normally express all three isotypes
- polymorphic in population
- codominant expresion= six stable heterodimers
- IFN-gamma upregulates expression
Nomenclature for HLA class II molecules
Class II MHC- major histocompatibility complex-any species
HLA-Class II- Human leukocyte antigen
H-2 mouse(histocompatibility-2 mouse IH2-IA, H2-IE
Human Class Region- HLA-DP, DQ, DR
dendricit cell antigen processing
endocytose into endosome and fuse with lysosome.
HLA class II molecules and innvariant chain are assmbled in
ER
complex HLA-class II=
trimeric, invariant chian blocks heterdimer antigen binding site
HLA class II is transported
in vesicles toward membrane
en route to membrane, HLA vesicles
fuse with endosome-lysosome vesicle and form chimeric vesicle
lysosomal enzymes degrade
invariant chain (Li)
antigen peptides bind to
groove in heterodimer
after antigen binds to chimeric vesicle it is
transported to and fused with membrane
both antigen and peptide complex on dendritic cells are
displayed on the cell surface.
activation interactions of dendritic and CD4+
HLA- class II peptide w/ t Cell antigen receptor -HLA class II receptor w/ CD4 -B7-1/CD80 w/ CD28(costimulatory) -B7-2/CD86 w/ CD28(costimulatory) - LFA-3 w/CD2 (adhesion - ICAM-1 w/ LFA-1(adhesion) - ICAM-2 w/LFA-1 (adhesion) - CD40 w/ CD40L (CD154) (enhances T cell response)
down regulation of ineraction of Dendritic cell with Tcell
B7-1/CD80 and B7-2/CD86 with CTLA4/CD152 causes inhibtion of T-cell
Cross presentation
process by which exogenous antigens(normally are processed in phagolysosomes) are presented on APC cell surface
only cell to mediate cross presentation for the most part
dendritic cells
following cross presentation exogenous antigens can be presented
within the context of Class I MHC, to CD8+
Antigen presenting cells
dendritic cells, macrophages(only CD4+ in primary response ), b-cells(Only to CD4+ in primary response) which all express FcgammaR
neutorphils and NK cells express
FcGamma R but are not APC
IN Vitro FLT3/CD135 regulates
differentiation, growth and survival of CD34+ progenitor cells.
dendritic receptors for chemokines direct them
to the secondary lymphoid tissue after they encounter an antigen
dendrites secrete cytokines when
they present to t- cells in the immune response site.
antigen presentation delivers the first
signal in T cell activation
MHC genes are located on
chromosome 6
Class II MHC restriction
CD4+ molecules only recognize antigenic peptides ifthey are displayed with Class II MHC molecules.
after association with class II MHC CD4+ cells
are further activated to secrete cytokines in the presence of costimulatory signals
when microbes thrive extracellularly some are
endocytosed by APCs
CD4
expressed by dendrite cells, determines T-cell lineage and function. is a receptor for HIV type 1
HIV-1 infection is initiated by
interaction of viral envelope proteins with CD4 and either CCr5/CXCR4
immature dendritic cells express both
CD4 and chemokine receptors.
people with defective CCR5 can be resistant to
infection with HIV-1